Hematologic Malignancies

eviti: Decision Support at the Point of Care for Oncologists

Arlene A. Forastiere, MD

May 2012, Vol 3, No 3 - Oncology

An independent health information technology company, eviti, Inc, provides a suite of web-based decision-support services that connects and delivers value to all parties in the care process—patients receive quality care, physicians are assured payment, insurers pay for quality care only, and pharmacy benefit managers (PBMs) or specialty pharmacy improve adherence. This decision support platform is a transformative solution that reduces variability in care, improves quality, and enables realignment of provider incentives.

[ Read More ]

The Pace of Change in Oncology Management Greater than the Sum of Its Parts

Lee Goldberg

December 2011, Vol 2, No 7 - Oncology

Innovative medications target the molecular structure of cancer cells with increasing precision, resulting in reduced adverse effects. Novel therapies enlist the patients’ own immune systems to defeat cancer. At the same time, as personalized medicine comes of age, improved diagnostic tests match the right patients to these new treatments. The accelerating pace of these developments is improving expectations of patient survivability and the total number of survivors.

[ Read More ]

Dose-Monitoring, Split-Fill Programs Reduce Oral Chemotherapy Waste, Save Costs

Caroline Helwick

August 2011, Vol 2, No 5 - Oncology

Dose-monitoring programs for oral chemotherapy drugs can reduce wastage and reduce the risk of serious adverse effects associated with these drugs. This translates into cost-savings for patients and for payers of >$2500 per patient, suggested researchers from Walgreens Specialty Pharmacy.

The company developed an oral chemotherapy cycle management program (CMP) that offers a “split-fill” option and close monitoring of pa - tients for adverse events. This is an optional program, and payers can elect to participate.

[ Read More ]

Northwestern University Comprehensive Cancer Center

August 2011, Vol 2, No 5 - Oncology

Interview with Al B. Benson III, MD, FACP

Professor of Medicine and Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL


Q: How would you define the concept of best practices, and what makes an oncology center, such as the Northwestern University Robert H. Lurie Comprehensive Cancer Center, be among the best oncology practices in the country?

[ Read More ]

The Impact of Therapy Type on Clinical Fragmentation in Oncology Care

Wayne Kuznar

July 2011, Vol 2, No 4 - Oncology

Philadelphia, PA—Fragmentation in oncology care significantly influences physicians’, payers’, and patients’ understanding of how cancer therapies lead to improved quality of care. The main reason for fragmentation is the challenge in linking pharmacy and medical data in a way that generates usable information, according to Atheer A. Kaddis, PharmD, Vice President, Managed Markets, Diplomat Specialty Pharmacy. [ Read More ]